Workflow
Hyperfine(HYPR)
icon
搜索文档
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
Businesswire· 2025-11-21 05:05
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference Share Contacts Media ContactDevin ZellHyperfinedzell@hyperfine.io GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain葉he Swoopョ system葉oday announced plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th ...
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
Businesswire· 2025-11-19 21:15
GUILFORD, Conn.--(BUSINESS WIRE)--$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities. ...
Hyperfine(HYPR) - 2025 Q3 - Earnings Call Transcript
2025-11-14 06:30
Hyperfine (NasdaqGM:HYPR) Q3 2025 Earnings Call November 13, 2025 04:30 PM ET Speaker2Good afternoon and welcome to Hyperfine's Third Quarter 2025 Earnings Conference Call. Currently, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Webb Campbell from Gill Martin Group for introductory disclosure.Speaker0Thank you for join ...
Hyperfine(HYPR) - 2025 Q3 - Earnings Call Presentation
2025-11-14 05:30
AI-POWERED, PORTABLE BRAIN MRI The Swoop® Portable MR Imaging System is Driving the Future of Brain Health Corporate Investor Deck – November 2025 The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo is a trademark of Hyperfine, Inc. PROPERTY OF HYPERFINE. ©2025. All rights reserved. Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigatio ...
Hyperfine(HYPR) - 2025 Q3 - Quarterly Report
2025-11-14 05:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________ FORM 10-Q _________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to_________ Commission File Number: 001-39949 _________________ Hyperfine, Inc. (Exact name of registrant a ...
After-Hours Gainers: MGNX, SLS, KRMD, HYPR, WVE Post Sharp Moves Following Q3 Updates
RTTNews· 2025-11-13 12:07
盘后股价表现 - 多只小盘医疗保健和生物科技股在周三盘后交易中出现显著上涨[1] - MacroGenics股价上涨10.2%至1.62美元[2] - SELLAS Life Sciences股价上涨9.4%至1.63美元[3] - Standard BioTools股价上涨4.24%至1.23美元[4] - KORU Medical Systems股价上涨8.47%至4.10美元[5] - Hyperfine股价上涨8.18%至1.19美元[6] - Wave Life Sciences股价上涨5.68%至7.35美元[7] 公司财务业绩 - MacroGenics第三季度净利润1680万美元或每股0.27美元 低于去年同期的5630万美元或每股0.90美元[2] - MacroGenics第三季度营收7280万美元 低于去年同期的1.107亿美元[2] - SELLAS Life Sciences第三季度净亏损收窄至680万美元或每股0.06美元 去年同期为710万美元或每股0.10美元[3] - SELLAS Life Sciences截至2025年9月30日现金及等价物约为4430万美元[3] - KORU Medical Systems第三季度净亏损收窄至80万美元 去年同期为160万美元[5] - KORU Medical Systems第三季度营收增长27.2%至1040万美元[5] - Wave Life Sciences第三季度净亏损5390万美元 较去年同期的6180万美元有所改善[7] - Wave Life Sciences第三季度营收760万美元 去年同期为负营收770万美元[7] 公司展望与预期 - KORU Medical Systems上调全年营收指引至4050万-4100万美元区间[5] - KORU Medical Systems重申毛利率展望为61%-63%[5] - Hyperfine计划于周四公布第三季度业绩 分析师预期每股亏损0.10美元 营收352万美元[6] - Standard BioTools和Hyperfine在周三盘后上涨时未发布官方新闻稿或更新[4][6]
Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting
Businesswire· 2025-10-21 20:15
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine launches study to assess Swoop® System use in neurosurgical ORs, advancing accessible brain MRI across care settings. ...
Satellogic, Hewlett Packard Enterprise, Bitfarms And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Bitfarms (NASDAQ:BITF), American Battery Tech (NASDAQ:ABAT)
Benzinga· 2025-10-16 20:01
美股期货市场表现 - 美国股指期货在周四早盘上涨 道指期货涨幅超过100点[1] Satellogic Inc (SATL) 股价异动 - 公司宣布进行新股公开发行提案 导致股价在盘前交易中大幅下跌131%至360美元[1] American Battery Technology Company (ABAT) 股价异动 - 美国能源部终止了对公司的拨款 导致股价在盘前交易中下跌239%至681美元[3] Hyperfine Inc (HYPR) 股价异动 - 公司公布的第三季度初步营收低于市场预期 同时宣布进行新股公开发行提案 导致股价下跌141%至189美元[3] Omeros Corporation (OMER) 股价异动 - 公司股价在周三因宣布诺和诺德收购其Zaltenibart全球权利而暴涨154%后 在盘前交易中回调下跌92%至945美元[3] Hewlett Packard Enterprise Company (HPE) 股价异动 - 公司第三季度财报显示受人工智能需求推动营收创纪录 但战略重组成本压缩了利润率 导致股价下跌86%至2285美元[3] NIO Inc (NIO) 股价异动 - 公司股价在盘前交易中下跌85%至624美元[3] Inventiva SA (IVA) 股价异动 - 公司在周三上涨10%后 于盘前交易中下跌75%至506美元[3] Bitfarms Ltd (BITF) 股价异动 - 公司宣布进行3亿美元的可转换优先票据发行 导致股价下跌46%至617美元[3] Rigetti Computing Inc (RGTI) 股价异动 - 公司首席执行官行使期权并计划于2025年5月21日转换100万股并立即出售 导致其持股归零 引发市场对管理层承诺的质疑 股价下跌48%至5366美元[3] Datavault AI Inc (DVLT) 股价异动 - 公司股价在盘前交易中下跌48%至200美元[3]
Satellogic, Hewlett Packard Enterprise, Bitfarms And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga· 2025-10-16 20:01
美股期货及市场整体表现 - 美国股指期货在周四早盘上涨 道指期货涨幅超过100点[1] Satellogic Inc (SATL) 股价异动 - Satellogic股价在盘前交易中大幅下跌131%至360美元 原因是公司宣布了一项拟议的公开售股计划[1] 其他盘前交易中下跌的个股 - American Battery Technology Company (ABAT) 股价下跌239%至681美元 因美国能源部于10月9日终止了对其的拨款[3] - Hyperfine, Inc. (HYPR) 股价下跌141%至189美元 因公司公布的第三季度初步收入低于预期 同时宣布了一项拟议的公开售股[3] - Omeros Corporation (OMER) 股价下跌92%至945美元 该股在周三因宣布诺和诺德收购其Zaltenibart全球权利而暴涨154%[3] - Hewlett Packard Enterprise Company (HPE) 股价下跌86%至2285美元 尽管其第三季度因AI需求创下营收纪录 但战略重组成本压缩了公司的利润率[3] - NIO Inc. (NIO) 股价下跌85%至624美元[3] - Inventiva S.A. (IVA) 股价下跌75%至506美元 该股在周三上涨了10%[3] - Bitfarms Ltd. (BITF) 股价下跌46%至617美元 因公司宣布了一项3亿美元的可转换优先票据发行[3] - Rigetti Computing, Inc (RGTI) 股价下跌48%至5366美元 公司CEO于2025年5月21日行使期权转换100万股并立即出售 导致其持股归零[3] - Datavault AI Inc. (DVLT) 股价下跌48%至200美元[3]
Hyperfine(HYPR) - 2025 Q3 - Quarterly Results
2025-11-14 05:11
财务数据关键指标变化 - 2025年第三季度初步预估总收入约为340万美元[4] - 截至2025年9月30日,预估现金及现金等价物约为2160万美元[4] 产品部署与商业推广 - 公司成功完成了下一代Swoop®系统的商业推广[9] - 公司将美国医院渠道全部转换为下一代Swoop®系统[9] - 下一代Swoop®系统已部署在医院渠道的所有关键护理点[9] 新市场与收入机会拓展 - 公司启动了办公场景的全面商业发布以开拓新收入机会[9] - 公司开始在美国、加拿大、澳大利亚和新西兰市场向已安装的Swoop®扫描仪基础推广Optive AI™软件[9]